The annual gross amount paid for the acquisition of fixed assets that are used repeatedly or continuously in the performance of R&D for more than one year.

They should be reported in full for the period when they took place, whether developed in-house or acquired, and should not be registered as an element of depreciation.

• Research and experimental development (R&D)